Trial shows Glaxo AIDS drug less effective
A clinical trial of Glaxo SmithKline Plc's AINDS drug Trizivir was halted after the drug was shown to be inferior to other combinations of medication, according to the National Institute of Health
A clinical trial of Glaxo SmithKline Plc's AINDS drug Trizivir was halted after the drug was shown to be inferior to other combinations of medication, according to the National Institute of Health